Clinical Trial

Cohort Study on Treatment of Cardiovascular Diseases With Traditional Chinese Medicine

Study acronym: CSCD-TCM plus
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 4, 2022 (before its estimated April 1, 2024 completion). Its status may not reflect the trial's current state.
Summary
This is a cohort study performed in patients with cardiovascular diaeases who were treated with oral Chinese medicine and Western medicine. Collect indicators such as the incidence of cardiovascular events, all due to readmission, all due to death. To hospital using clinical samples to detect genomics, proteomics, metabolomics, intestinal flora and sclerotia.To explore the clinical efficacy of Chinese patent medicine in the treatment of cardiovascular diseases, and provide reliable data support for its clinical application.
Trial Details
NCT Number NCT05309343
Lead Sponsor Tianjin University of Traditional Chinese Medicine
Conditions Cardiovascular Diseases
Enrollment 20,000 participants
Start Date 2021-11-01
Primary Completion 2024-04-01 (estimated)
Study Completion 2031-11-01 (estimated)
Updated on ClinicalTrials.gov 2022-04-04